Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
History
Business
Sports
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/27/2b/3b/272b3bb5-41f6-80c8-bdb5-59ba42490021/mza_13022196809781523932.jpg/600x600bb.jpg
Improzone
Improzo
7 episodes
1 week ago
You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.
Show more...
Life Sciences
Science
RSS
All content for Improzone is the property of Improzo and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/44231618/44231618-1755005322279-fe9bdd7ce0063.jpg
Season 1 Episode 4.3 - Using Third-Party Tools with AI Inside
Improzone
20 minutes 45 seconds
1 month ago
Season 1 Episode 4.3 - Using Third-Party Tools with AI Inside

In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision.

In this episode, we unpack:

- The Limits of Questionnaires: Why paper surveys fail to catch GenAI hallucinations.

- Brand vs. Security: Why a secure bot can still be toxic.

- Continuous Validation: Why a one-time pen test is already obsolete.

Join Jane Urban and Nathan Trueblood for a masterclass in AI procurement safety.

#ArtificialIntelligence #PharmaTech #DigitalHealth #RiskManagement #AIEthics #VendorManagement #TechLeadership #EnkryptAI #Improzo

Improzone
You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.